Regional Business Manager - New England
Intellia Therapeutics, Inc.
July 01, 2026
On-site
Cambridge, MA
Sales
Responsibilities
- Territory planning and account development for immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers across ME, NH, MA, and RI.
- Prioritize high-value accounts; build trusted advisor relationships with KOLs, clinical champions, and administrative decision-makers.
- Manage a sales pipeline from initial awareness through patient treatment completion.
- Educate providers on in vivo CRISPR mechanisms; differentiate MOA vs prophylactics, complement inhibitors, and plasma-derived therapies.
- Present Phase III efficacy/safety data; address CRISPR safety misconceptions.
- Maintain competitive intelligence; develop value propositions; handle objections (technology, permanent genetic modification, single-treatment cost).
- Educate patients on diagnosis-to-treatment pathway; integrate hub services for seamless access.
- Partner with Medical Affairs, Field Reimbursement, and Strategic Accounts teams to support medical needs, payer strategy, and site activation.
Qualifications & Skills
- Comprehensive HAE knowledge; understanding of CRISPR/gene editing and regulatory requirements.
- Ability to analyze/present complex clinical trial data and real-world evidence.
- Exceptional scientific communication; relationship management; creative problem solving.
- Growth and competitive mindset; business-owner execution and results orientation.
- BS/BA in life sciences or business.
- Preferred/required experience: 5+ years specialty pharmaceutical sales (rare disease/immunology/genetic medicines preferred); rare disease commercialization; product launch experience; success in long complex sales cycles (12–18 months).
Application
- Applications accepted on a rolling basis until the position is filled.
Compensation/Benefits (if applicable)
- Performance-based annual cash bonus, new-hire equity grant, and eligibility for annual equity awards.
- Territory planning and account development for immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers across ME, NH, MA, and RI.
- Prioritize high-value accounts; build trusted advisor relationships with KOLs, clinical champions, and administrative decision-makers.
- Manage a sales pipeline from initial awareness through patient treatment completion.
- Educate providers on in vivo CRISPR mechanisms; differentiate MOA vs prophylactics, complement inhibitors, and plasma-derived therapies.
- Present Phase III efficacy/safety data; address CRISPR safety misconceptions.
- Maintain competitive intelligence; develop value propositions; handle objections (technology, permanent genetic modification, single-treatment cost).
- Educate patients on diagnosis-to-treatment pathway; integrate hub services for seamless access.
- Partner with Medical Affairs, Field Reimbursement, and Strategic Accounts teams to support medical needs, payer strategy, and site activation.
Qualifications & Skills
- Comprehensive HAE knowledge; understanding of CRISPR/gene editing and regulatory requirements.
- Ability to analyze/present complex clinical trial data and real-world evidence.
- Exceptional scientific communication; relationship management; creative problem solving.
- Growth and competitive mindset; business-owner execution and results orientation.
- BS/BA in life sciences or business.
- Preferred/required experience: 5+ years specialty pharmaceutical sales (rare disease/immunology/genetic medicines preferred); rare disease commercialization; product launch experience; success in long complex sales cycles (12–18 months).
Application
- Applications accepted on a rolling basis until the position is filled.
Compensation/Benefits (if applicable)
- Performance-based annual cash bonus, new-hire equity grant, and eligibility for annual equity awards.